Results 41 to 50 of about 1,515,055 (315)

Reducing routine laboratory tests in patients with isolated extremity fractures: a prospective safety and feasibility study in 246 patients

open access: yesPatient Safety in Surgery, 2019
Background Daily routine laboratory testing is unnecessary in most admitted patients. The opportunity to reduce daily laboratory testing in orthopaedic trauma patients has not been previously investigated.
Raj. M. Amin   +7 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Seedling Stage Corn Line Detection Method Based on Improved YOLOv8

open access: yes智慧农业
[Objective]Crop line extraction is critical for improving the efficiency of autonomous agricultural machines in the field. However, traditional detection methods struggle to maintain high accuracy and efficiency under challenging conditions, such as ...
LI Hongbo   +7 more
doaj   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

A SHDAViT-MCA Block-Based Network for Remote-Sensing Semantic Change Detection

open access: yesRemote Sensing
This study addresses the challenge of accurately detecting agricultural land-use changes in bi-temporal remote sensing imagery, which is hindered by cross-temporal interference, multi-scale feature modeling limitations, and poor large-area scalability ...
Weiqi Ren   +8 more
doaj   +1 more source

Wavelet bispectrum-based nonlinear features for cardiac murmur identification

open access: yesCogent Engineering, 2018
Cardiac or heart sound ca.rries important diagnosis information for several cardiovascular diseases, such as natural or prosthetic valve dysfunction and heart failure.
Dinesh Kumar   +2 more
doaj   +1 more source

Understanding the Stability of Forest Reserve Boundaries in the West Mengo Region of Uganda

open access: yesEcology and Society, 2006
Despite heavy pressure and disturbance, state property regimes have stemmed deforestation within protected areas of the West Mengo region of Uganda for over 50 yr.
Nathan D. Vogt   +3 more
doaj   +1 more source

A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

open access: yesScientific Reports, 2021
Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted radiopharmaceutical therapy (RPT) has enabled significant imaging and prostate-specific ...
Srikanth Boinapally   +8 more
doaj   +1 more source

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy